Back to Results
First PageMeta Content
Dividend / Annual general meeting / Financial ratios / Economics / Canada Steamship Lines / Paul Martin / CSL Limited


916CRN2225_CSL_CSL_Limited_Annual_General_Meeting_enCompass_Sep2014_v1.indd
Add to Reading List

Document Date: 2014-09-11 19:47:48

Open Document

File Size: 708,81 KB

Share Result on Facebook

City

Bern / Kankakee / Marburg / Melbourne / Broadmeadows / /

Company

2014 CSL Limited / Listed Company / enCompass / CSL Limited / Janssen / /

Continent

Asia / North America / Europe / /

Country

Germany / Switzerland / New Zealand / United States / Australia / China / /

Currency

NZD / AUD / USD / /

Event

Security Buyback / Dividend Issuance / General or Shareholder Meeting / Business Partnership / FDA Phase / /

Facility

National Tennis Centre / Function Centre / D pipeline / Biotechnology Manufacturing Facility / /

IndustryTerm

plasma products / manufacturing capacity expansion programs / biotechnology manufacturing facility / therapy for haematological cancer / therapies for rare and serious diseases / /

MarketIndex

S&P/asx 20 / /

Organization

Australian Government / National Tennis Centre / FDA / Notes and Explanatory Notes Board of Directors / Function Centre / /

Person

David Anstice Bruce Brook Marie / Shi Shine / John Akehurst David Anstice Bruce / Paul Perreault / Bruce Brook / Maurice Renshaw Edward / Bruce Brook Marie McDonald Christine / John Shine / /

Position

Director The Managing / Major Products / Bailey Company Secretary / important driver / General / Chairman / Professor / Director / Managing Director / AO Chairman Board of Directors John Shine / Annual General / director fee cap / /

Product

Kcentra® / /

Technology

biotechnology / /

URL

www.investorvote.com.au / www.csl.com.au / /

SocialTag